Author(s)

Xiaoqi Li ¹, Kai Qu ^1,2, Xia Shen ¹, Xiancheng Li ², Xiaoyong Yu ²

Affiliation(s)

¹ Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China
² Shaanxi Provincial Hospital of Traditional Chinese Medicine, Xi'an, Shaanxi, 710003, China

Corresponding Author

Kai Qu

ABSTRACT

To explore the significance of Huangqi in the treatment of DN, this article explored the potential targets and signaling pathways of Astragalus-Chinese yam-Salvia miltiorrhiza in the intervention of diabetic nephropathy (DN), based on GEO database combined with network pharmacology and molecular docking. The relevant chips of DN were searched by GEO database, and the chemical active substances and corresponding targets in Astragali Radix, Dioscoreae Rhizoma and Salviae Miltiorrhizae Radix et Rhizoma were screened by TCMSP database, and the intersection with differentially expressed genes was taken. Then, the PPI network diagram was constructed by String database and Cytoscape 3.9.0 software respectively, and the gene GO and KEGG enrichment analysis were carried out by R language, and the above research results were verified by molecular docking. The results of molecular docking showed that the receptors IL6 and IL1 B could stably bind and interact with quercetin, diosgenin and luteolin. Thus, the active components such as quercetin, luteolin and diosgenin of Astragalus-Dioscorea-Salvia miltiorrhiza play a therapeutic role in DN by acting on IL6, IL1 B, MM9 and other targets, regulating AGE-RAGE and other signaling pathways.

KEYWORDS

Network pharmacology; GEO database; astragalus; yam; danshen; diabetic nephropathy; molecular docking

CITE THIS PAPER

Xiaoqi Li, Kai Qu, Xia Shen, Xiancheng Li, Xiaoyong Yu, Study on Mechanism of Huangqi-Shanyao-Danshen Compatibility in Treatment of Diabetic Nephropathy Based on GEO Database and Network Pharmacology and Molecular Docking. MEDS Chinese Medicine (2023) Vol. 5: 98-106. DOI: http://dx.doi.org/10.23977/medcm.2023.050616.

REFERENCES

[1] Pugliese G. Updating the natural history of diabetic nephropath [J]. Acta Diabetol, 2014, 51(6): 905-915. 
[2] Diabetes Branch of Chinese Medical Association. Chinese guidelines for the prevention and treatment of type 2 diabetes (2017 edition) [J]. Chinese Journal of Diabetes, 2018, 10(1):4-67. 
[3] Xiao Yao, Zhao Jinxi. Zhao Jinxi's experience in the treatment of diabetic nephropathy [J]. Chinese Journal of Traditional Chinese Medicine, 2018, 33(01):159-162. 
[4] Lin Yadong, Zhang Fuzhi, Lei Lei, et al. Analysis of medication rule of traditional Chinese medicine in the treatment of diabetic nephropathy based on data mining [J]. Chinese Journal of Traditional Chinese Medicine Information, 2020, 27(05):102-106. 
[5] Wang Jing, Liu Yan, Guo Hongmin. Effect of Astragalus on improving urinary L-FABP in patients with early type 2 diabetic nephropathy [J]. Hunan Journal of Traditional Chinese Medicine, 2022, 38(10):22-26. 
[6] Zhang Wenjie, Lai Xinghai, Chen Jiawei. The effect of yam polysaccharide on obese diabetic nephropathy rats and its effect on renal function and intestinal microecology [J]. Chinese Journal of Microecology, 2021, 33(01):37-42. 
[7] Sun Shengkui, Fan Yinyan, Zuo Lina, et al. Effect of Bailing capsule combined with salvianolate on renal function and blood glucose in elderly patients with stage IV diabetic nephropathy [J]. World Chinese Medicine, 2019, 14(09): 2400-2403. 
[8] Wu Yiling, Wei Cong, Jia Zhenhua, et al. To explore the pathogenesis of diabetic nephropathy from collateral disease theory [J]. Chinese Journal of Basic Medicine of Traditional Chinese Medicine, 2007(09):659-660. 
[9] Ding Yingjun, Xiao Yonghua, Fu Qiang, et al. Analysis of the pathological hypothesis of diabetic nephropathy 'micro Zhengjia ' [J]. Chinese Journal of Traditional Chinese Medicine, 2009, 24(01):27-30. 
[10] Guan Qianqian. Study on the preparation technology of yam powder based on anti-diabetic activity and special medical staple food [D]. Yangzhou University, 2018. 
[11] Fu Xiao. Effect of astragaloside IV on the expression of urotensin II and its receptor in renal tissue of diabetic nephropathy rats [D]. Shanxi Medical University, 2022. 
[12] Li Yan. Effect of astragaloside IV on GSDMD and caspase-1 expression in renal tissue of diabetic nephropathy rats [D]. Shanxi Medical University, 2022. 
[13] Zhang Xianming, Yang Jinping, Mao Qiong, et al. Effects of astragalus polysaccharides on renal function, neutrophil / lymphocyte ratio, Th_1, Th_2 and Th_1 / Th_2 values in patients with diabetic nephropathy [J]. Chinese folk therapy, 2022, 30(06):80-82. 
[14] He Zhiting, Zhao Jing, Feng Ling, et al. The effect of tanshinone IIA injection on the treatment of maintenance hemodialysis patients with type 2 diabetic nephropathy and the levels of IGF-1 and plasma protein C [J], 2021, 32(22): 2861-2864. 
[15] Forney L A, Lenard N R, Stewart L K, et al. Dietary quercetin attenuates adipose tissue expansion and inflammation andalters adipocyte morphology in a tissue-specific manner [J]. International Journal of Molecular Sciences, 2018, 19(3):E895. 
[16] Tang L X, Li K, Zhang Y, et al. Quercetin liposomes ameliorate streptozotocin-induced diabetic nephropathy in diabetic rats[J]. Scientific Reports, 2020, 10(1):2440. 
[17] Zhao Jialing. Protective effect of luteolin on renal mesangial cells in high glucose environment by activating Nrf2 pathway [D]. Nanjing University of Traditional Chinese Medicine, 2014. 
[18] Zhang Xinxin. Studies on the Chemical Constituents and Pharmacological Actions of Dioscorea zingiberensis [D]. Northwestern University, 2015. 
[19] Chen Liping, Chen Lebao, Lou Ruitao, etc. Correlation between interleukin-6 and type 2 diabetic nephropathy [J]. Chinese community physician, 2020, 36(32):24-25. 
[20] Liu Wei, Yu Hongbing. Correlation analysis of plasma IL-1β and PGE_2 levels in patients with type 2 diabetes mellitus and diabetic nephropathy [J], 2021, 19(09):54-56. 
[21] Ma Zhongchao, Xie Tingting, Sun Xiaoping, et al. Analysis of risk factors for atherosclerosis in patients with diabetic nephropathy [J]. Chinese modern doctors, 2022, 60(26):62-67. 
[22] Zhang Yunxiang, Li Haili. Study on the correlation between serum advanced glycation end products, uric acid and the progression of type 2 diabetic nephropathy [J]. Medical theory and practice, 2022, 35(09):1562-1565.

Sponsors, Associates, and Links

---

• MEDS Clinical Medicine
  
  
• Journal of Neurobiology and Genetics
  
  
• Medical Imaging and Nuclear Medicine
  
  
• Bacterial Genetics and Ecology
  
  
• Transactions on Cancer
  
  
• Journal of Biophysics and Ecology
  
  
• Journal of Animal Science and Veterinary
  
  
• Academic Journal of Biochemistry and Molecular Biology
  
  
• Transactions on Cell and Developmental Biology
  
  
• Rehabilitation Engineering & Assistive Technology
  
  
• Orthopaedics and Sports Medicine
  
  
• Hematology and Stem Cell
  
  
• Journal of Intelligent Informatics and Biomedical Engineering
  
  
• MEDS Basic Medicine
  
  
• MEDS Stomatology
  
  
• MEDS Public Health and Preventive Medicine
  
  
• Journal of Enzyme Engineering
  
  
• Advances in Industrial Pharmacy and Pharmaceutical Sciences
  
  
• Bacteriology and Microbiology
  
  
• Advances in Physiology and Pathophysiology
  
  
• Journal of Vision and Ophthalmology
  
  
• Frontiers of Obstetrics and Gynecology
  
  
• Digestive Disease and Diabetes
  
  
• Advances in Immunology and Vaccines
  
  
• Nanomedicine and Drug Delivery
  
  
• Cardiology and Vascular System
  
  
• Pediatrics and Child Health
  
  
• Journal of Reproductive Medicine and Contraception
  
  
• Journal of Respiratory and Lung Disease
  
  
• Journal of Bioinformatics and Biomedicine